Agilon Health (NYSE:AGL) Shares Gap Down – Time to Sell?

Shares of Agilon Health, Inc. (NYSE:AGL) gapped down prior to trading on Tuesday . The stock had previously closed at $92.54, but opened at $86.85. Agilon Health shares last traded at $89.06, with a volume of 8,165 shares traded.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Wells Fargo & Company restated an “overweight” rating and set a $146.00 price target (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Barclays set a $111.00 target price on Agilon Health and gave the company an “equal weight” rating in a research report on Thursday, August 6th. Truist Financial set a $112.00 price target on Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. Finally, Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Agilon Health currently has a consensus rating of “Hold” and an average price target of $97.70.

Agilon Health Price Performance

The stock has a 50 day simple moving average of $103.62 and a two-hundred day simple moving average of $64.44. The firm has a market cap of $1.47 billion, a PE ratio of -6.15 and a beta of 3.01. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. Sell-side analysts expect that Agilon Health, Inc. will post -2.33 earnings per share for the current year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds have recently bought and sold shares of AGL. Rubicon Founders LLC acquired a new stake in shares of Agilon Health during the 2nd quarter worth approximately $11,290,448. Great Lakes Advisors LLC purchased a new stake in Agilon Health during the second quarter worth $702,000. Alpine Global Management LLC purchased a new stake in Agilon Health during the fourth quarter worth $84,000. Corient Private Wealth LP acquired a new stake in Agilon Health during the second quarter valued at $406,000. Finally, California State Teachers Retirement System acquired a new stake in Agilon Health during the second quarter valued at $1,976,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.